Radhika Aiyappa‐Maudsley
University of Leeds(GB)St James's University Hospital(GB)Wellcome Trust(GB)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Pharmacogenetics and Drug Metabolism, Cancer, Hypoxia, and Metabolism, Cell Adhesion Molecules Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → Intratumoural Cytochrome P450 Expression in Breast Cancer: Impact on Standard of Care Treatment and New Efforts to Develop Tumour-Selective Therapies(2021)49 cited
- → The role of interleukin-8 (IL-8) and IL-8 receptors in platinum response in high grade serous ovarian carcinoma(2015)47 cited
- → High expression of integrin β6 in association with the Rho–Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers(2016)41 cited
- → Factors affecting the radiation response in glioblastoma(2022)25 cited
- → HR+HER2− breast cancers with growth factor receptor–mediated EMT have a poor prognosis and lapatinib downregulates EMT in MCF-7 cells(2017)12 cited
- → CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer(2022)11 cited
- → Semaphorins and Their Roles in Breast Cancer: Implications for Therapy Resistance(2023)10 cited
- → Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle(2023)9 cited
- → In vitro radiosensitization of breast cancer with hypoxia‐activated prodrugs(2022)8 cited
- → A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor‐positive disease(2023)5 cited